Skip to content

Achieve Life Sciences ACHV Total Current Liabilities

Total Current Liabilities at other companies

Pfizer logo
PfizerPFE
$34.35B-5.8%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$9.78M+2.6%
Philip Morris International logo
Philip Morris InternationalPM
$26.22B-6.6%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's total current liabilities?
Achieve Life Sciences (ACHV) reported total current liabilities of $11.83M in Q1 2026.
How has Achieve Life Sciences's total current liabilities changed year-over-year?
Achieve Life Sciences's total current liabilities increased by 66.0% year-over-year, from $7.13M to $11.83M.
What is the long-term trend for Achieve Life Sciences's total current liabilities?
Over 5 years (2020 to 2025), Achieve Life Sciences's total current liabilities has grown at a 25.3% compound annual growth rate (CAGR), from $2.94M to $9.08M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.